clinical trial · NCT00648778
Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg
HealthyLoxapine Succinate Capsules 25 mgLoxitane® Capsules 25 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan loxapine succinate 25 mg capsules to Watson Loxitane 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administration under fasting conditions.
started
Jan 1, 2003
primary completion
Feb 1, 2003
completion
Feb 1, 2003
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Loxapine Succinate Capsules (25 mg; Mylan) and Loxitane® Capsules (25 mg; Watson) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol